« Media center

APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study

15 September 2010

APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study on Zolmitriptan RapidFilm®, and its upcoming submission for registration in Europe.

PR_APR_Labtec_ZOL_ODF_Sept2010_Final.pdf

Also on:
Linkedin

Main activities

Other activities

APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study

Progetto Talenti

Cultura e salute